USFDA pulls up Jagsonpal Pharmaceuticals for manufacturing lapses at API plant
The US health regulator has pulled up Jagsonpal Pharmaceuticals for significant manufacturing lapses at its Rajasthan-based active pharmaceutical ingredients (APIs) plant. In a warning letter issued to the company’s Managing…